Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC

ASCO 2026: Updates in renal cancer

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Understanding patient expectations and clinicians' goals in favourable risk aRCC patients

ASCO 2026: Comment: Multi-cancer earlier detection tests

Aspirin in stage III colorectal cancer shows no significant DFS benefit but favourable safety

MCED blood test trial fails primary end point, but screening cut number of cancers found at stage IV

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer